sb 203580 has been researched along with hydrogen sulfide in 6 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (hydrogen sulfide) | Trials (hydrogen sulfide) | Recent Studies (post-2010) (hydrogen sulfide) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 8,039 | 83 | 5,149 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ii, H; Imai, T; Kamoda, T; Murata, T; Sato, T; Yaegaki, K | 1 |
| Ekuni, D; Ii, H; Imai, T; Irie, K; Morita, M; Yaegaki, K | 1 |
| Bröll, J; Kloesch, B; Liszt, M; Steiner, G | 1 |
| Cao, Q; Pei, Y; Teng, H; Wang, R; Yang, G | 1 |
| Feng, J; Guo, R; Lin, J; Mo, L; Shen, N; Xu, W; Zhang, C | 1 |
| Chen, J; Feng, J; Guo, R; He, J; Liu, C; Lu, Y; Zhang, W; Zhang, Y; Zhen, Y | 1 |
6 other study(ies) available for sb 203580 and hydrogen sulfide
| Article | Year |
|---|---|
Oral malodorous compound inhibits osteoblast proliferation.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Butadienes; Cell Differentiation; Cell Proliferation; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Halitosis; Humans; Hydrogen Sulfide; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines | 2009 |
Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Topics: Acid Phosphatase; Animals; Blotting, Western; Calcium Phosphates; Calcium-Calmodulin-Dependent Protein Kinases; Cathepsin K; Cell Differentiation; Cell Line; Enzyme Inhibitors; Flavonoids; Halitosis; Hydrogen Sulfide; Imidazoles; Isoenzymes; Macrophages; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2010 |
Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2.
Topics: Butadienes; Cell Line; Chondrocytes; Drug Antagonism; Enzyme Inhibitors; Gene Expression; Humans; Hydrogen Sulfide; Imidazoles; Interleukin-1beta; Interleukin-6; Interleukin-8; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines | 2012 |
Specificity protein-1 as a critical regulator of human cystathionine gamma-lyase in smooth muscle cells.
Topics: Air Pollutants; Animals; Antibiotics, Antineoplastic; Antigens, Differentiation; Cell Differentiation; Cells, Cultured; Cystathionine gamma-Lyase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Hydrogen Sulfide; Imidazoles; Mice; Mice, Knockout; Muscle Proteins; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Plicamycin; Pyridines; Response Elements; RNA, Messenger; Sp1 Transcription Factor | 2011 |
Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Topics: Acetylcysteine; Animals; Apoptosis; Cardiotoxins; Cell Line; Cell Survival; Doxorubicin; Hydrogen Sulfide; Imidazoles; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Myocytes, Cardiac; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Reactive Oxygen Species | 2013 |
Exogenous hydrogen sulfide promotes C6 glioma cell growth through activation of the p38 MAPK/ERK1/2-COX-2 pathways.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glioma; Hydrogen Sulfide; Imidazoles; MAP Kinase Signaling System; Nitrobenzenes; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Rats; Sulfonamides | 2015 |